Commentary on Japanese Pediatric Guideline for the Treatment and Management of Asthma 2017 Chapter 14 List of principal anti-asthmatic agents-Reference-Cited by-同舟云学术

Commentary on Japanese Pediatric Guideline for the Treatment and Management of Asthma 2017 Chapter 14 List of principal anti-asthmatic agents

Published:2019 Issue:3 Volume:33 Page:340-343
ISSN:0914-2649
Container-title:Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunology
language:en
Short-container-title:Nihon Shoni Arerugi Gakkaishi. The Japanese Journal of Pediatric Allergy and Clinical Immunollogy

Author:

Yamada Yoshiyuki¹,Arakawa Hirokazu²

Affiliation:

1. Division of Allergy and Immunology, Gunma Children' s Medical Center, Gunma, Japan

2. Department of Pediatrics, Gunma University Graduate School of Medicine, Gunma, Japan

Publisher

Japanese Society of Pediatric Allergy and Clinical Immunology

Subject

Ocean Engineering

Link

https://www.jstage.jst.go.jp/article/jspaci/33/3/33_340/_pdf

Reference7 articles.

1. 4) Strauss RE, et al. Aminophylline therapy does not improve outcome and increases adverse effects in children hospitalized with acute asthmatic exacerbations. Pediatrics 1994 ; 93 : 205-210.

2. 5) Yoshihara S, et al. The use of patch formulation of tulobuterol, a long-acting beta2-adrenoreceptor agonist, in the treatment of severe pediatric asthma. Ann Allergy Asthma Immunol 2006 ; 96 : 879-880.

3. 6) Baughman RP, Loudon RG. The utility of a long-acting sympathomimetic agent, procaterol, for nocturnal asthma. Chest 1988 ; 93 : 285-258.

4. 7) Yoshihara S, et al. Comparative study of skin permeation profiles between brand and generic tulobuterol patches. Biol Pharm Bull 2010 ; 33 : 1763-1765.

5. 8) Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2013.